K M Kam Selected Research

K M Kam Research Topics

5	Tuberculosis (Tuberculoses) 11/2014 - 09/2007
2	Syphilis 01/2014 - 02/2010
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 02/2013 - 05/2000
2	Infections 08/2006 - 09/2000
1	Nasopharyngeal Carcinoma 10/2007
1	Granuloma 09/2007
1	Neoplasms (Cancer) 08/2006
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2006
1	Bacteremia 09/2000
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2000
1	Pulmonary Tuberculosis 06/2000
1	Chronic Disease (Chronic Diseases) 06/2000

2	EnzymesIBA 01/2014 - 02/2010
2	IceIBA 01/2014 - 02/2010
2	Pharmaceutical PreparationsIBA 11/2013 - 06/2000
2	Rifampin (Rifampicin)FDA LinkGeneric 02/2013 - 06/2000
2	Isoniazid (Ftivazide)FDA LinkGeneric 02/2013 - 06/2000
1	Antitubercular AgentsIBA 11/2013
1	Interferon-gamma (Interferon, gamma)IBA 12/2010
1	GoldIBA 12/2010
1	Immunoglobulin G (IgG)IBA 02/2010
1	carbol-fuchsin solutionIBA 01/2009
1	ChemokinesIBA 09/2007
1	Chemokine CCL5IBA 09/2007
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2007
1	Tuberculin (PPD)IBA 08/2006
1	16S Ribosomal RNAIBA 09/2000
1	AcidsIBA 06/2000
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 06/2000